Web Market News

  The global digital biomarkers market size is expected to reach USD 13,966.16 million by 2030 , registering a CAGR of 21.9% during the forecast period, according to a new report by Grand View Research, Inc. Due to the rising acceptance of recent advancements and remote technologies, the market for digital biomarkers is anticipated to expand throughout the forecast period.   Development of the remote data collecting technologies, which make up the largest segment of the market for digital biomarkers, has been propelled by the improvements in wearable and mobile technology. Additionally, this market segment is being further assisted by the growing use of the internet. Vocal digital biomarkers in particular have lately come into existence and offer enormous business development potential. They enable easy data collection through voice recordings and through patient-owned technology like cell phones, wearables, and other devices. Vocal biomarkers are being utilized more frequently, wh

  The global physical vapor deposition market size is expected to reach USD 5.0 billion by 2030 , according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.5% from 2022 to 2030 . The market is significantly driven by the increasing demand for semiconductors, electronic, and solar products across the world. Physical vapor deposition are used for the functional lifetime coating of semiconductor components by depositing non-metal and chemical-resistant oxides on the surfaces. The coating process increases its lifetime and enhances functionality. The rising demand for semiconductors driven by the increasing usage of consumer electronic products is likely to fuel market growth. Additionally, PVD is used for the coating process in solar panels and photovoltaic cells. The rising installation of solar products across the world is expected to increase the demand for PVD coating. According to Solar Energy Industry Association, new installations of solar products in th

  The Thailand legal cannabis market size is expected to reach USD 9.6 billion by 2030 , according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 58.4% from 2022 to 2030 . The growth is attributed to the rising usage of cannabis for recreational and medical purposes. Cannabis legalization has opened new revenue-generating opportunities for various industries in the country. The adoption of CBD oil and tinctures for treating various ailments like nausea, anxiety, and cancer along with the rising prevalence of cancer are some of the significant factors boosting the industry’s growth. The growing burden of chronic pain has also augmented the rise in the usage of CBD for treatments related to pain management and thus, positively impacting the market growth. Various studies have shown positive outcomes of marijuana and its derivatives to treat symptoms of several chronic conditions. For instance, it has been effectively used to treat patient

  The U.S. child care market size is expected to reach USD 83.6 billion by 2030 , based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.18% from 2023 to 2030 . The key factors driving the growth include an increase in awareness regarding early education, high demand for early education centers, and an increase in the number of working parents. In addition, the advancement in learning technologies for children is resulting in further growth opportunities. Public awareness campaigns and government programs have increased awareness about child education & development in the U.S. The National Center for Healthy Safe Children is spreading awareness regarding the development of the child & need for developing skills at an early age. Factors such as the growing disposable income in the U.S. and the interest of parents to give top-quality care & early education to their children are also resulting in higher demand for early education

  The global single-use bioreactors market size is expected to reach USD 12.06 billion by 2030 , registering a CAGR of 17.19% from 2023 to 2030 , according to a new report by Grand View Research, Inc. Owing to the rising demand for biopharmaceuticals, coupled with increasing investments in single-use technologies, the market for single-use bioreactors is expected to witness significant growth throughout the forecast period. Furthermore, the COVID-19 outbreak has positively impacted the market for SUBs. The race to create an effective vaccine against the SARS-CoV-2 virus is being undertaken by numerous biopharmaceutical firms. As a result, the need for single-use bioreactors has drastically increased. For instance, in October 2020, ABEC supplied six 4,000 L single-use bioreactors to the Serum Institute of India, for the production of COVID-19 vaccines on a large scale at a reasonable cost. The value of the product, the time required for product development and production, in additi

  The global left atrial appendage closure devices market size is expected to reach a value of USD 5.7 billion by 2030 , registering a CAGR of 20.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of atrial fibrillation (AF) is expected to raise the left atrial appendage closure (LAAC) devices demand during the forecast period, which will further boost the market development. The most prevalent arrhythmic condition in the world, AF affects more than 2.3 million individuals in the United States and 4.5 million in the European Union. With age, the incidence and disorder burden of AF increases, accounting for 15% of all strokes. The left atrial appendage (LAA) closure devices market has been greatly impacted by COVID-19. The pandemic prompted non-urgent operations, such as structural heart (SH) interventional surgery to be postponed or canceled, thereby, negatively impacting the market during 2020. The COVID-19 outbreak had a

  The global rat model market size is expected to reach USD 2.41 billion by 2030 , according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.81% from 2022 to 2030 . Genetically modified organisms are extensively used in research for identifying potential therapeutic targets and further validation of the same. The extensive healthcare-based research has driven the market for understanding diseases and genetic illnesses of humans. During the COVID-19 outbreak, researchers were focused on understanding the pathogenesis and transmission of the SARS-CoV2 virus by using the readily available animal model in addition to in-vitro and ex-vivo culture systems. These models also helped in the evaluation of vaccines and antivirals for the treatment. Companies creating transgenic animals used this as a perfect opportunity to provide the scientific community with genetically modified rats for evaluation of SARS-Cov2 entry. For example, in 2020,Envigo created the hACE2 knock